Provention Bio Q3 EPS $(0.24) Down From $(0.17) YoY

Provention Bio (NASDAQ:PRVB) reported quarterly losses of $(0.24) per share. This is a 41.18 percent decrease over losses of $(0.17) per share from the same period last year.

Benzinga · 11/05/2019 21:27

Provention Bio (NASDAQ:PRVB) reported quarterly losses of $(0.24) per share. This is a 41.18 percent decrease over losses of $(0.17) per share from the same period last year.